BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang Y, Alderman C, Sehlaoui A, Xiao Y, Wang W. MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers. Can J Gastroenterol Hepatol 2018;2018:9740357. [PMID: 30046565 DOI: 10.1155/2018/9740357] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Cao K, Sun L, Zhang Y, Wang T, Li H, Zuo S. [Overpression of miR-29b suppresses the proliferation and induces apoptosis of cholangiocarcinoma cells]. Nan Fang Yi Ke Da Xue Xue Bao 2018;38:1234-8. [PMID: 30377134 DOI: 10.3969/j.issn.1673-4254.2018.10.13] [Reference Citation Analysis]
2 Nazari N, Jafari F, Ghalamfarsa G, Hadinia A, Atapour A, Ahmadi M, Dolati S, Rostamzadeh D. The emerging role of microRNA in regulating the mTOR signaling pathway in immune and inflammatory responses. Immunol Cell Biol 2021;99:814-32. [PMID: 33988889 DOI: 10.1111/imcb.12477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ahangar NK, Hemmat N, Khalaj-Kondori M, Shadbad MA, Sabaie H, Mokhtarzadeh A, Alizadeh N, Derakhshani A, Baghbanzadeh A, Dolatkhah K, Silvestris N, Baradaran B. The Regulatory Cross-Talk between microRNAs and Novel Members of the B7 Family in Human Diseases: A Scoping Review. Int J Mol Sci 2021;22:2652. [PMID: 33800752 DOI: 10.3390/ijms22052652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ng L, Li X, Wan TM, Iyer D, Sin RW, Lo OS, Foo DC, Law WL. Investigation of miRNA dysregulation and association with immune cell profile during malignant transformation of colorectal cells. Eur J Surg Oncol 2021:S0748-7983(21)00742-3. [PMID: 34620510 DOI: 10.1016/j.ejso.2021.09.016] [Reference Citation Analysis]
5 Peruhova M, Peshevska-Sekulovska M, Krastev B, Panayotova G, Georgieva V, Konakchieva R, Nikolaev G, Velikova TV. What could microRNA expression tell us more about colorectal serrated pathway carcinogenesis? World J Gastroenterol 2020; 26(42): 6556-6571 [PMID: 33268946 DOI: 10.3748/wjg.v26.i42.6556] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 De Silva S, Tennekoon KH, Karunanayake EH. Interaction of Gut Microbiome and Host microRNAs with the Occurrence of Colorectal and Breast Cancer and Their Impact on Patient Immunity. Onco Targets Ther 2021;14:5115-29. [PMID: 34712050 DOI: 10.2147/OTT.S329383] [Reference Citation Analysis]
7 Mafi S, Mansoori B, Taeb S, Sadeghi H, Abbasi R, Cho WC, Rostamzadeh D. mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment. Front Immunol 2022;12:774103. [DOI: 10.3389/fimmu.2021.774103] [Reference Citation Analysis]
8 Taheri F, Ebrahimi SO, Shareef S, Reiisi S. Regulatory and immunomodulatory role of miR-34a in T cell immunity. Life Sci 2020;262:118209. [PMID: 32763292 DOI: 10.1016/j.lfs.2020.118209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Grenda A, Krawczyk P, Błach J, Chmielewska I, Kubiatowski T, Kieszko S, Wojas-Krawczyk K, Kucharczyk T, Jarosz B, Paśnik I, Borowiec-Bar M, Frąk M, Kieszko R, Szczyrek M, Reszka K, Krukowska K, Kolak A, Mańdziuk S, Kowalski D, Sawicki M, Świniuch D, Starosławska E, Ramlau R, Szumiło J, Krzakowski M, Milanowski J. Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients. Front Oncol 2020;10:563613. [PMID: 33628725 DOI: 10.3389/fonc.2020.563613] [Reference Citation Analysis]